Top Markets
Coin of the day
Intellipharmaceutics International Inc. Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc.

IPCI
Clasificación en acciones #37499
Intellipharmaceutics International Inc., founded in Toronto, Canada, in 1998,... Intellipharmaceutics International Inc., founded in Toronto, Canada, in 1998, is a pharmaceutical company that focuses on the research, development, and manufacturing of innovative and generic controlled-release and targeted-release oral solid dosage medications, primarily for the United States market. The company leverages its patented Hypermatrix technology to create advanced drug delivery systems, an array of product candidates, and a robust pipeline across diverse therapeutic areas, including neurological, cardiovascular, gastrointestinal, diabetes, and pain management conditions. Its current product portfolio includes extended-release formulations like Focalin XR for hyperactivity disorder, Keppra XR for partial onset seizures, Effexor XR to treat depression, and Protonix for gastroesophageal reflux disease. Other offerings feature Glucophage XR for type 2 diabetes, Seroquel XR for schizophrenia and mood disorders, Lamictal XR for epilepsy, Pristiq for depression, Coreg CR for heart failure and hypertension, and Ranexa for chronic angina. Furthermore, Intellipharmaceutics is actively developing additional controlled-release drugs such as OxyContin for pain relief and Regabatin XR for neuropathic pain management. The company operates under a license and commercialization agreement with Par Pharmaceutical Inc.
Precio por acción
$0.05897422
Última sincronización: 2024-04-02
Capitalización bursátil
$1.64M
Cambio (1 día)
0.07%
Cambio (1 año)
-60.68%
País
CA
Comercio Intellipharmaceutics International Inc. (IPCI)

Categoría

Historial del precio de la acción de Intellipharmaceutics International Inc. (IPCI)
Precio más alto de cierre: $0.15 el 2024-11-01

Precio más bajo de cierre: $31.12 el 2009-10-01
Historial del precio de la acción de Intellipharmaceutics International Inc. desde 2009 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 112.59%
2023 -4.41%
2022 -40.30%
2021 -12.82%
2020 -62.91%
2019 52.31%
2018 -96.81%
2017 -71.95%
2016 34.10%
2015 -16.93%
2014 -27.82%
2013 48.06%
2012 -19.79%
2011 11.50%
2010 56.05%
2009 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$514.89 35.60%
US
$182.73 608.53%
US
$125.92 -4.58%
AU
$948.14 29.11%
NL
$730.39 7.23%
CH